Why You Have an Increased Risk of Invokana Kidney Failure
In March 2016, Joan Mullin filed a complaint against Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. She claims that Janssen failed …
Cherokee Nation Throws Risperdal Lawsuit at J&J
Cherokee Nation faces Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, in Oklahoma state court over Risperdal’s dangerous side effects. …
J&J’s Risperdal Appeal Denied by Supreme Court
The Supreme Court won’t hear Johnson & Johnson’s Risperdal appeal anytime soon. As the highest court in the land, the …
Risperdal and Gynecomastia: Physical & Psychological Side Effects
Risperdal and Gynecomastia: Physical Impact The way the body changes during puberty is enough to make even the healthiest young …
Diabetic Ketoacidosis: The Invokana DKA Side Effect
Once diagnosed, type 2 diabetes demands lifestyle changes. Dietary changes. Physical activity changes. You must carefully monitor and regulate blood …
$327+M in Risperdal Payouts and Verdicts No Deterrent for J&J
$327 million—that was the verdict handed down in 2011 against Johnson & Johnson’s subsidiary, Janssen Pharmeceuticals, for illegally marketing Rispderal. …
Invokana Complications: Are Patients Made Aware?
Once again, Johnson & Johnson subsidiary Janssen Pharmaceuticals faces scrutiny. Now, it’s for allegedly failing to properly inform patients of …
Risperdal Attorneys and the Massive Class Action Settlement
An ongoing Risperdal settlement is underway against drug manufacturer Janssen Pharmaceuticals and their parent company, Johnson & Johnson. Risperdal attorneys …
The Irony of Risperdal Gynecomastia
Risperdal is one of the greatest medical ironies. That’s because young boys taking it for severe psychosis may develop Risperdal …
Risperdal Can Lead to Male Breasts, Psychological Scarring
Powerful drugs come with powerful side effects. Risperdal effectively treats several mental illnesses, but can also cause significant damage. One …
Risperdal Manufacturers Docked Again For Failure-to-Warn
A trial in the Philadelphia Court of Common Pleas reached another verdict on a case concerning Johnson & Johnson’s drug Risperdal on Friday, March 20, ruling that while the company failed to adequately warn about a major side effect, it would not award damages to plaintiff William Cirba.
Risperdal Gynecomastia Lawsuits Are Back on the Rise
Risperdal, an antipsychotic developed by the Janssen brand of Johnson & Johnson, has long been approved by the Food and Drug Administration for schizophrenia.
Xarelto Complications Surpass the Competition
Xarelto is a fairly new drug on the market, and it’s a blood thinner that helps prevent the risk of stroke.
Risperdal Verdicts: The Drug Worth Two Fortunes
Risperdal verdicts and lawsuit settlements have been piling up since 2012 after consumers learned that Johnson & Johnson had been marketing …